Socio demographic

Related by string. socio demographic * socios . Socios . socio : socio economically disadvantaged . ASEAN Socio Cultural . socio economic . socio politico economic . Socio economic . socio politico / DEMOGRAPHICS . DEMOGRAPHIC . Demographics . demographics . Demographic : demographic characteristics . demographic trends . Demographic Trends . changing demographics . demographic variables * *

Related by context. All words. (Click for frequent words.) 70 sociodemographic characteristics 69 Sociodemographic 68 sociodemographics 66 socio demographic 66 sociodemographic factors 65 Socioeconomic status 63 premorbid 63 Univariate 62 multivariate analyzes 62 Symptom severity 62 sociodemographic 62 APOE genotype 61 Univariate analysis 61 Heritability 61 neurocognitive functioning 61 sociodemographic variables 61 bivariate analyzes 61 syndromic 61 psychiatric morbidity 61 nonpsychotic 61 socioeconomic variables 60 familial aggregation 60 noncognitive 60 multiple linear regression 60 comorbid anxiety 60 multiple logistic regression 60 comorbid psychiatric 60 cognitive affective 60 multivariable adjusted 60 serum estradiol 60 psychiatric comorbidity 59 covariate 59 meta regression 59 autonomic dysfunction 59 mean ± SEM 59 Comorbidity 59 NHAMCS 59 logistic regression analyzes 59 bivariate 59 chronicity 59 neurocognition 59 generalisability 59 comorbid depression 58 genotype phenotype 58 clinicopathologic 58 schizophreniform disorder 58 ANCOVA 58 generalized estimating 58 Comorbid 58 affective psychosis 58 interobserver 58 spirometric 58 cervicitis 58 clinico pathological 58 differential gene expression 58 tumor histology 58 comorbid disorders 58 limiting generalizability 58 socioeconomic status SES 58 CORE OM 58 cerebral oxygenation 58 Correlates 58 clinicopathological 58 socioeconomic deprivation 58 psychosocial stressors 57 Histopathologic 57 Subgroup analyzes 57 etiologic 57 multivariate logistic regression 57 echocardiographic parameters 57 neurocognitive impairment 57 somatoform disorders 57 serum lipid levels 57 Cognitive behavioral 57 preoperative intraoperative 57 EQ 5D 57 BPS IC 57 alexithymia 57 allele frequencies 57 socioeconomic characteristics 57 demographic variables 57 GABRA2 57 Statistical analyzes 57 neurocognitive function 57 diabetes mellitus hypertension 57 frontostriatal 57 SF #v# 57 Multivariate logistic regression 57 Prevalence 57 univariate analyzes 57 euthymic 56 Longitudinal studies 56 affective disorders 56 Electrophysiological 56 gastric cardia 56 HRQOL 56 methodologic 56 multivariable analyzes 56 Main Outcome Measures 56 opioid prescribing 56 ethnicity socioeconomic status 56 Child Behavior Checklist 56 schizophrenia schizoaffective disorder 56 Pharmacologic 56 depressive symptomatology 56 Modifiable risk 56 urodynamic parameters 56 antenatal depression 56 Poisson regression 56 familial clustering 56 antipsychotic prescribing 56 Framingham Offspring 56 psychosocial variables 56 IPAH 56 esophageal reflux 56 nonpsychiatric 56 susceptibility locus 56 potentially modifiable 56 metaanalysis 56 ski lls 56 pharmacodynamic parameters 56 Heterogeneity 56 meta analytic review 56 logistic regression model 56 bivariate analysis 55 Anthropometric 55 Multivariate analyzes 55 Fibroblast growth 55 neuropsychological functioning 55 #q# deletion syndrome 55 NAMCS 55 comorbidity 55 mania hypomania 55 menstrual irregularity 55 erection hardness 55 Genetic predisposition 55 Histologic 55 Histopathological 55 comorbid psychiatric disorders 55 comorbid illnesses 55 affective psychoses 55 daytime somnolence 55 neurosensory 55 HER2 expression 55 electrophysiologic 55 GH deficiency 55 anthropometric measurements 55 Neurocognitive 55 DSM IV Axis 55 hyper IgE syndrome 55 ABCB1 gene 55 renal cysts 55 Histological 55 thyrotropin levels 55 disable virulence 55 serum PTH 55 serum folate concentrations 55 CHD mortality 55 persistency mortality 55 BMI z 55 odds ratios ORs 55 convergent validity 55 Assessment Questionnaire 55 shorter telomere length 55 generalisable 55 systolic diastolic 55 Comorbidities 55 metabolite concentrations 55 heritable variation 55 se xual 55 predictive validity 54 unfavorable prognostic 54 adiponectin concentrations 54 HIV HCV coinfected 54 acute febrile 54 psychometric properties 54 Suicidal ideation 54 confidence intervals CIs 54 multivariate adjustment 54 Outcome Measures 54 Meta analyzes 54 CYP#D# genotype 54 inflammatory biomarkers 54 Determinants 54 seropositivity 54 multivariable adjustment 54 Sociocultural 54 Phenotypic 54 HRQoL 54 paternally inherited 54 Genetic variants 54 headache abdominal pain 54 Skin sterol 54 neurocognitive dysfunction 54 oxidative stress markers 54 acute respiratory tract infections 54 BRFSS 54 subclinical disease 54 demographic characteristics 54 neuritic 54 interindividual variability 54 mortality morbidity 54 Prefrontal 54 hormone receptor status 54 choline intake 54 proband 54 suicide attempters 54 GABRA2 gene 54 psychosocial distress 54 venous thromboembolic disease 54 MDRD 54 Multivariate analysis 54 EORTC QLQ C# 54 postintervention 54 Multiple logistic regression 54 Genetic susceptibility 54 % CI #.#-#.# [008] 54 Logistic regression 54 neuroanatomical 54 vasomotor 54 Tasigna prolongs 54 causal pathway 54 fibroids endometriosis 54 subscale scores 54 Heavy menstrual bleeding 54 multivariate statistical 54 MTHFD1L gene 54 TT genotype 54 perseverative 54 Pharmacodynamic 54 diathesis 54 covariates 54 tumor subtype 54 salivary cortisol 54 neuropsychological assessment 54 serum BDNF 54 internalizing disorders 54 parasitological 54 schizophreniform 54 Nonmedical 54 visceral adiposity 54 VLBW 54 multivariable logistic regression 54 multivariable Cox 54 CVD mortality 54 Epidemiologic 54 polygenic 54 meta analytic 54 retrospectively analyzed 54 phylogenetic analyzes 54 lymphocyte subsets 54 abdominal adiposity 54 urolithiasis 54 serum lactate 54 psychophysiological 54 conducted retrospective cohort 54 Antigenic 53 toxicologic 53 Charlson comorbidity index 53 de novo mutations 53 coronary microvascular 53 genetic loci 53 psychosocial functioning 53 Genetic variations 53 suicide ideation 53 prevalences 53 psychiatric comorbidities 53 left ventricular diastolic 53 maturational 53 Depressive symptoms 53 Psychodynamic 53 HRQL 53 nondemented 53 Factors influencing 53 metabolic dysregulation 53 subsyndromal 53 Socioeconomic 53 untreated psychosis 53 histologic subtype 53 Multivariate analysis revealed 53 PLMs 53 inferential statistics 53 obesity sedentary lifestyle 53 dyslipidaemia 53 chronic obstructive airway 53 CYP#D# inhibitor 53 elevated fasting glucose 53 multivariate regression 53 Suboptimal 53 Predisposition 53 diabetes hypertension hyperlipidemia 53 anthropometric 53 hypertension coronary 53 dopamine receptor gene 53 stepwise logistic regression 53 CIBIC + 53 perinatal outcomes 53 Serologic 53 attain statistical significance 53 gene polymorphisms 53 Lipodystrophy 53 plasma adiponectin 53 multivariate regression analysis 53 anthropometric measures 53 #q# deletion 53 neuropsychological deficits 53 alcoholic liver cirrhosis 53 Socioeconomic factors 53 syndromal 53 Multivariate 53 sociologic 53 univariate 53 BEXXAR Therapeutic Regimen 53 chi squared 53 Neuropsychological 53 poststroke 53 Genotypic 53 impaired cognition 53 prospective observational cohort 53 testicular germ cell 53 Brief Psychiatric 53 multivariable analysis 53 psychiatric inpatients 53 schizotypal 53 biobehavioral 53 psychoeducation 53 depression suicidal ideation 53 Charlson Comorbidity Index 53 THIS STUDY analyzed 53 tic severity 53 depressive symptom 53 lipid elevations 53 subscores 53 waist circumference WC 53 linear regression analyzes 53 hypovitaminosis D 53 physiological nutritional 53 Multivariable logistic regression 53 mammographic density 53 OPRM1 53 haematologic 53 somatization 53 semistructured interviews 53 Main Outcome Measure 53 comorbid substance 53 nondepressed 53 hyperactivity inattention 53 Atkins dieters cardiovascular 53 guideline concordant 53 thyroid carcinoma 53 chronic prostatitis chronic 53 impaired glucose metabolism 53 DNA methylation patterns 53 mucosal inflammation 53 STRATEGY FOR AN OPEN 53 STEP BD 53 MYH9 53 retrospective cohort 53 Depressive Symptoms 53 Insulin sensitivity 53 pharmacologic treatments 53 somatoform disorder 53 axial length 52 mild renal insufficiency 52 correlated inversely 52 postdischarge 52 statistically significant correlation 52 fractional anisotropy 52 collagen vascular 52 glucocorticoid induced 52 emotional dysregulation 52 NHANES III 52 Current Beneficiary 52 tertiles 52 HIV seropositive 52 cytokines chemokines 52 psychiatric outpatients 52 #q#.# deletion syndrome 52 logistic regression analysis 52 temporoparietal 52 aged ≥ 52 Hormonal Contraceptives 52 acute subacute 52 electroencephalograms 52 Treatment Outcome 52 WOMAC scores 52 MYH9 gene 52 albumin excretion rate 52 Immunologic 52 microscopic colitis 52 histologic findings 52 Marital status 52 logistic regression models 52 pain catastrophizing 52 lymphomas leukemias 52 obstructive sleep 52 gait disturbance 52 gastric carcinoma 52 Female Sexual Function 52 5 HTTLPR genotype 52 underdiagnosis 52 ejaculatory function 52 parkinsonian 52 sensory gating 52 nutrient intakes 52 pretransplant 52 diagnosing ADHD 52 hematological parameters 52 CYP#D# gene 52 androgen excess 52 HDL cholesterol triglycerides 52 functional gastrointestinal disorders 52 dietary calcium intake 52 EEG abnormalities 52 callous unemotional traits 52 intraobserver 52 LUTS 52 Preexisting 52 Seasonal Pattern 52 cortical atrophy 52 psychobiological 52 biopsychosocial 52 glycaemia 52 NCDB 52 Adverse effects 52 Mantel Haenszel 52 Nonalcoholic fatty liver 52 neuropathologic 52 PKC inhibitors 52 hemodynamic measurements 52 Breslow thickness 52 postnatally 52 coagulation abnormalities 52 nonparametric 52 overnight polysomnography 52 urodynamic 52 comorbid conditions 52 symptom severity 52 ventilation perfusion 52 Thromboembolic 52 comorbid 52 lipodystrophy syndrome 52 Diagnostic Criteria 52 semistructured 52 Logistic regression analysis 52 Morphological 52 cerebral glucose metabolism 52 multivariate Cox 52 hyperlipidaemia 52 genomewide 52 Neuropsychiatric 52 Prevalence Estimates 52 exhaled nitric oxide eNO 52 genes differentially expressed 52 arterial thickening 52 cytologic 52 OSAHS 52 NLSY 52 symptomatology 52 Neuroticism 52 albumin excretion 52 Generalized Anxiety Disorder 52 conditional logistic regression 52 Substance misuse 52 corneal thickness 52 explanatory variables 52 diabetes dyslipidemia 52 antiphospholipid antibodies 52 interindividual 52 inhaled bronchodilators 52 Disordered eating 52 Cardiorespiratory fitness 52 neuropsychological assessments 52 comorbid diagnoses 52 aetiological 52 urodynamic studies 52 leukocyte counts 52 posttreatment 52 Ocular Surface Disease 52 bronchoalveolar lavage 52 plasma lipid 52 physico chemical 52 aminotransferase 52 bone metabolism 52 Irritability anxiety cognitive 52 authors hypothesized 52 Goltz syndrome 52 unmeasured confounders 52 somatic symptoms 52 psychopathological 52 ultrastructural 52 nonbacterial prostatitis 52 MetS 52 RRM1 52 urinary cadmium 52 electroencephalographic 52 chlamydial infection 52 AJPH 52 penetrance 52 susceptibility loci 52 Nicotine dependence 52 Insulin Sensitivity 51 flashbacks nightmares depression 51 HRCT 51 intelligence quotient IQ 51 CC genotype 51 phytoestrogen intake 51 Overviews 51 nonepileptic seizures 51 inversely associated 51 etiological 51 hyperhomocysteinemia 51 GBA mutations 51 GBS colonization 51 NHANES #-# 51 logistic regressions 51 Prospective Cohort Study 51 WOMAC pain 51 prognostic variables 51 observable characteristics 51 micronutrient intake 51 chromosomal anomalies 51 elevated serum ALT 51 G6PD deficiency 51 bronchoalveolar lavage fluid 51 peri natal 51 parous women 51 prospective observational studies 51 glutamate glutamine 51 univariate analysis 51 hypercoagulable 51 thyrotropin 51 prothrombotic 51 PIB PET 51 Kaplan Meier curve 51 perceptual reasoning 51 Descriptive statistics 51 carotid plaque 51 observable traits 51 generalizability 51 T1DM 51 unmeasured confounding 51 Negative Symptoms 51 Chlamydia trachomatis infection 51 clinicopathological features 51 externalizing behaviors 51 abnormal lipid 51 hematopoietic cancers 51 logistic regression 51 thiopurine 51 WCST 51 prenatal exposures 51 proton MR spectroscopy 51 alpha defensin 51 residual confounding 51 familial pancreatic cancer 51 hypertension diabetes mellitus 51 Methodological 51 impaired insulin secretion 51 intraclass correlation coefficients 51 Cytogenetic 51 Categorising 51 orthologous genes 51 Modifiable 51 Multiple linear regression 51 serum retinol 51 Dental caries 51 Testosterone deficiency 51 prostate carcinogenesis 51 polycystic ovary 51 Chronic Renal Failure 51 diabetes mellitus DM 51 Functional Outcomes 51 bacterial prostatitis 51 oesophageal adenocarcinoma 51 Demographic 51 gonococcal 51 PLX STROKE targeting 51 primary aldosteronism 51 Cardiotoxicity 51 Kidney Function 51 neurobehavioural 51 hypometabolism 51 Posttraumatic 51 Suicidal thoughts 51 Psychotropic medications 51 nonpatient 51 HIV seroprevalence 51 Psychosocial interventions 51 atherothrombotic disease 51 coinfected patients 51 multiplicative 51 negative affectivity 51 serum leptin 51 confusional 51 body fatness 51 autism dyslexia 51 baseline LDH 51 Genetic variation 51 KDOQI 51 Outcomes Study 51 serum GGT 51 observational cohort study 51 atherothrombotic 51 cerebral microbleeds 51 Dyslipidemia 51 convulsive disorders 51 mu opioid 51 Bacterial vaginosis 51 retrospective cohort study 51 prepregnancy 51 Gestational 51 Mechanistic 51 strongest predictors 51 Chronic pelvic 51 ApoE gene 51 Exacerbations 51 colorectal cancer incidence 51 coexisting illnesses 51 System IPSS 51 pharmacotherapeutics 51 symptom checklist 51 SMBG 51 antioxidant supplementation 51 antiplatelet medications 51 cardio respiratory fitness 51 longitudinal cohort study 51 laterality 51 FGFs 51 cognitive behavioral therapies 51 airway responsiveness 51 autopsied brains 51 inhibin B 51 familial predisposition 51 asymptomatic bacteriuria 51 prenatal phthalate exposure 51 marital statuses 51 Obsessive compulsive disorder OCD 51 Randomized Controlled Trials 51 variance ANOVA 51 collected saliva samples 51 Neuropsychiatric Inventory NPI 51 metabolic dysfunction 51 Anxiety Depression 51 SCN1A 51 APOE ε4 51 NRF2 gene 51 hypertension cardiovascular disease 51 pathophysiological mechanisms 51 causal pathways 51 autosomal dominant inheritance 51 rs# [004] 51 atherosclerotic cardiovascular 51 subscales 51 epistasis 51 MMSE score 51 noncardiovascular mortality 51 gender disaggregated 51 scintigraphic 51 Secondary efficacy endpoints 51 fluoroquinolone resistance 51 regression equations 50 inflammation metabolic disorders 50 genomic alterations 50 anti Mullerian hormone 50 HIV seronegative 50 prognostic indicators 50 Immunohistochemical 50 Haplotype 50 hypoactive 50 abnormal lipid levels 50 Spending Patterns 50 Sleep disturbances 50 Cognitive impairment 50 baroreflex sensitivity 50 coinfection 50 microstructural 50 allelic 50 prefrontal cortical 50 segmented regionally 50 psychotherapeutic drugs 50 perfusion abnormalities 50 antiretroviral naïve 50 CYP#C# gene 50 FOR AN OPEN 50 adverse perinatal 50 CRP concentrations 50 causal inference 50 Atomoxetine 50 developmental trajectories 50 Edinburgh Postnatal Depression 50 carotid artery ultrasounds 50 psycho physiological 50 chromosome #p# [002] 50 SIADH 50 CPAP adherence 50 Perinatal Mortality 50 Relapsing remitting MS 50 Multiethnic Cohort Study 50 thyroid hormone levels 50 subclinical atherosclerosis 50 socioeconomic status 50 confounder 50 urinary bowel 50 lethargy irritability 50 CKD MBD 50 prostate abnormalities 50 Physiologic 50 rheumatologic 50 prospectively stratified 50 serum selenium 50 deCODE BreastCancer TM 50 Psychiatric Epidemiology 50 physiologic parameters 50 Functional neuroimaging 50 immunosuppression therapy 50 endocrinological 50 Observational studies 50 carotid plaques 50 functional neuroimaging 50 PCOD 50 EGFR mutation status 50 Correlations 50 sulcal 50 Alpha Tocopherol Beta Carotene 50 xi unanticipated 50 anterior pituitary 50 Urogenital 50 serum lipid 50 Chemotherapy induced 50 Genotypes 50 normal karyotype 50 empirically validated 50 cTnT 50 neuropsychological impairments 50 Bioavailability 50 autoimmune thyroid 50 FACIT 50 extensive metabolizers 50 Extrinsic 50 immunotoxicity 50 potential confounding variables 50 nosology 50 #:#-#,# CrossRef Medline [002] 50 gastroesophageal reflux GERD 50 Sexual Satisfaction 50 bronchial hyperresponsiveness 50 diffusion tensor 50 Psychotic Disorders 50 genetic relatedness 50 genetic polymorphisms 50 Cronbach alpha 50 indications contraindications 50 chorioamnionitis 50 Medication adherence 50 antiphospholipid syndrome 50 urogenital 50 rs# [001] 50 advanced neoplasia 50 Subtypes 50 endocrinologic 50 underlying pathophysiology 50 Neuropsychologia 50 PON1 gene 50 hypochondriasis 50 fasting plasma 50 plasma leptin 50 histopathologic diagnosis 50 asplenia 50 prospectively enrolled 50 airway hyperresponsiveness 50 hepatic enzyme 50 modifiable lifestyle 50 www.nimh.nih.gov 50 psychopharmacological 50 maintaining cardiorespiratory fitness 50 serologic testing 50 histological subtype 50 Such forwardlooking 50 lithological controls 50 elevated ALT 50 HCUP 50 Kruskal Wallis test 50 ascertainment bias 50 HIV tropism 50 transrectal ultrasound guided 50 hydroxyvitamin D concentrations 50 inattention hyperactivity 50 Serological 50 multicentric 50 AML MDS 50 serum parathyroid hormone 50 Multicenter AIDS 50 abstinent alcoholics 50 fibrosis progression 50 genotypic resistance 50 Clinicaltrials.gov 50 induced akathisia 50 Seattle Angina Questionnaire 50 Multifactor productivity 50 abnormal cytology 50 nonadherence 50 Quantifiable 50 behaviourial 50 hMG 50 neuropathological 50 Campylobacter spp 50 observable behaviors 50 neuropsychological evaluations 50 nasal polyposis 50 tumor subtypes 50 cardio metabolic 50 anal HPV 50 nonhereditary 50 prospective multicentre 50 monoamine 50 Nonalcoholic Fatty Liver Disease 50 adiponectin levels 50 bone marrow mesenchymal stem 50 obesity insulin resistance 50 gallstone disease 50 ragweed allergic 50 posttransplant 50 androgen deficiency 50 intact parathyroid hormone 50 umol L 50 nonalcoholic steatohepatitis NASH 50 immune dysregulation 50 puerperal 50 micronutrient supplementation 50 antimicrobial susceptibility 50 causative mutations 50 Erectile function 50 methylenetetrahydrofolate reductase 50 gestational diabetes mellitus GDM 50 abnormal clotting 50 hyperuricaemia 50 somatization disorder 50 fructosamine 50 interrater 50 Mood disorders 50 BPRS 50 β = 50 ANOVA 50 Correlating 50 Posttraumatic stress disorder 50 AGGRASTAT R tirofiban hydrochloride 50 Thyroid disorders 50 LIST OF FIGURES 50 Intervention Trial 50 eczema asthma 50 COMT genotype 50 atherothrombosis 50 ABCB1 50 overt hypothyroidism 50 serum homocysteine 50 anticholinergic agents 50 Postmenopausal hormone therapy 50 heritable component 50 Posttraumatic Stress 50 HMGA1 50 Single Nucleotide Polymorphisms 50 idiopathic intracranial hypertension 50 microarray gene expression 50 relapsed MM 50 Autistic Spectrum Disorders 50 cross sectionally 50 baseline CD4 50 multisystemic 50 daytime alertness 50 Symptom Checklist 50 endothelial activation 50 cystic fibrosis chronic pancreatitis 50 folate concentrations 50 Matthew Hurles 50 irregular menses 50 MS DRG 50 vascular dysfunction 50 glycosylated hemoglobin HbA1c 50 Suicidal Behavior 50 Evaluable 50 etiologic factors 50 apparent diffusion coefficient 50 reproductive tract infections 50 IntroductionThe 50 BRCA1 BRCA2 50 Tumor Response 50 psychopathological symptoms 50 DSM IV diagnostic 50 Longitudinal 50 intracellular signal transduction 50 Social Phobia 50 TOP2A gene 50 endometrial thickness 50 lipid lowering agents 50 Postural 50 dyslipidemia hypertension 50 underwent coronary angiography 49 dichotomized 49 National Epidemiologic Survey 49 chronic renal insufficiency 49 interrater reliability 49 circulating endothelial cells 49 congenital deficiency 49 bioavailable testosterone 49 metabolic syndrome MetS 49 % CI #.#-#.# [005] 49 FeNO 49 papillary renal cell carcinoma 49 Subarachnoid hemorrhage 49 Quantification 49 oncogenic transformation 49 atopic disorders 49 BMC Psychiatry 49 depression schizophrenia bipolar 49 antidiabetic medications 49 serum phosphate 49 Urinary tract infection 49 endocrine metabolic 49 quantitatively assess 49 Hill Rom enhancing 49 #:#-# [029] 49 endophenotypes 49 seroprevalence 49 CFQ R 49 GPRD 49 arterial oxygen saturation 49 undergoing coronary angiography 49 Visual Analogue Scale VAS 49 prospective longitudinal 49 HIV sero 49 glaucomatous 49 genital arousal 49 hyperreflexia 49 irritability lethargy 49 discriminant 49 mitochondrial DNA mtDNA 49 autistic traits 49 CHD CVD 49 Psychosocial 49 microbiologic 49 CAVEATS 49 levodopa induced 49 5 HTTLPR 49 Sheen cited irreconcilable 49 Cystatin C 49 NSDUH 49 neuromotor 49 cross tabulations 49 Fibromyalgia Impact Questionnaire 49 Hippocampal 49 suboptimal adherence 49 Primary endpoints 49 urinary BPA 49 Cognitive Functioning 49 pretreatment serum 49 SGRQ 49 See CLINICAL PHARMACOLOGY 49 postmenopausal hormone 49 posterior cingulate 49 plasma homocysteine 49 posttest 49 Agreeableness 49 Etiology 49 coronary calcification 49 Pelvic inflammatory 49 genotypic 49 Pneumococcal vaccination 49 Antidepressants Linked 49 Ischemic heart 49 #HT#A receptor 49 fasting serum 49 femoral neck fracture 49 serotonin deficiency 49 neuro physiological 49 semiquantitative 49 steroidogenic 49 SCK difficulty 49 varenicline Chantix 49 Richard Suzman Ph.D. 49 Bacterin proprietary 49 selective agonists 49 highly heritable 49 cortical activation 49 CSF biomarkers 49 cortisol secretion 49 severe periodontitis 49 demyelinating 49 radiographic findings 49 Psychiatric Morbidity 49 Catheter Associated 49 biologic DMARDs 49 euthymic patients 49 autonomic instability irregular 49 linkage disequilibrium LD 49 Autistic Disorder 49 embryonic lethality 49 childhood acute lymphoblastic 49 Attention-Deficit/Hyperactivity Disorder ADHD

Back to home page